Group 1 - The recommendation for Health Catalyst (NASDAQ: HCAT) is a buy rating, indicating a positive outlook for the company's future performance [1] - The new Ignite platform is identified as a major growth catalyst that is expected to drive growth for the foreseeable future [1] - The investment approach focuses on long-term investments while also incorporating short-term strategies to uncover alpha opportunities, emphasizing a bottom-up analysis of individual companies [1] Group 2 - The investment duration is medium to long-term, aiming to identify companies with solid fundamentals, sustainable competitive advantages, and growth potential [1]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its charter ...

Health Catalyst (HCAT) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this provider of data analytics for the health care industry would post earnings of $0.11 per share when it actually produced earnings of $0.04, delivering a surprise of -63.64%.Over the last four quarters, the company has surpassed consensus EPS es ...

Health Catalyst (HCAT) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Company Participants Jack Knight - VP - Investor RelationsDan Burton - CEODan Lesueur - COOJason Alger - Chief Financial OfficerAnne Samuel - Executive DirectorJared Haase - Equity Research AssociateElizabeth Anderson - Senior Managing DirectorRichard Close - Managing Director Digital and Tech-Enabled Health Equity ResearchJenny Shen - Equity Research AssociateScott Schoenhaus - Managing DirectorJeff Garro - Managing Director Conference C ...

Health Catalyst (HCAT) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Speaker0 Welcome to the Health Catalyst First Quarter twenty twenty five Earnings Conference Call. Now I would like to turn the conference over to Jack Knight, Vice President of Investor Relations. Please go ahead, sir. Speaker1 Good afternoon, and welcome to Health Catalyst's earnings conference call for the first quarter of twenty twenty five, which ended on 03/31/2025. My name is Jack Knight. I am the Vice President of Investor Relatio ...

Health Catalyst Reports First Quarter 2025 Results SALT LAKE CITY, UT, May 7, 2025 — Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. "For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance ...

SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. "For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric," said Dan Burton, C ...

SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2025 operating results on Wednesday, May 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. partici ...

SALT LAKE CITY, April 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Health Catalyst Ignite Spark™, a tailored data and analytics solution built for community health systems, regional hospitals, and multi-site practices. Smaller community health systems across the U.S. are navigating shrinking margins, policy uncertainty, and rising pressure to deliver ...

Core Insights - Health Catalyst (NASDAQ: HCAT) is highlighted as a valuable addition to the Bio Boom Portfolio, indicating its potential for growth and investment opportunity [1]. Company Overview - The article emphasizes the author's long-term investment in Health Catalyst, suggesting confidence in the company's future performance [2]. - The author has a background in healthcare investment, focusing on innovative companies that develop breakthrough therapies and pharmaceuticals [1]. Investment Strategy - The investment strategy includes a focus on companies with catalysts for potential acquisitions, which may enhance their market value [1].